Bulletin
Investor Alert

AbbVie Inc.

NYS: ABBV

GO
/marketstate/country/us

After Hours

/zigman2/quotes/202428675/composite

$

153.12

Change

-0.04 -0.03%

Volume

Volume 412,167

Jun 30, 2022, 7:59 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/202428675/composite

Previous close

$ 154.14

$ 153.16

Change

-0.98 -0.64%

Day low

Day high

$150.87

$154.04

Open
Open: 153.17

52 week low

52 week high

$105.56

$175.91

Open

Market cap

$272.38B

Average volume

7.01M

P/E ratio

21.96

Rev. per Employee

$1.13M

EPS

6.97

Dividend

1.41

Div yield

3.68%

Ex dividend date

7/14/22

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/abbv

MarketWatch News on ABBV

  1. 2 Companies That Raised Their Dividends This Week

    4:00 a.m. June 25, 2022

    - Lawrence C. Strauss

  2. Making Stocks Safer With High-Yield Bonds

    4:30 p.m. June 24, 2022

    - Lewis Braham

  3. Who Will Lead Biogen? Here Are Some Likely Picks.

    11:13 a.m. May 24, 2022

    - Josh Nathan-Kazis

  4. Berkshire Hathaway exited Bristol Myers and AbbVie stakes in Q1

    5:53 p.m. May 16, 2022

    - Dow Jones Newswires

  5. How to Avoid the Biotech Bear Market: Get Some Products Approved

    7:39 p.m. May 13, 2022

    - Josh Nathan-Kazis

  6. Only 18 stocks in the S&P 500 are trading up

    2:46 p.m. May 5, 2022

    - Tomi Kilgore

  7. Pfizer Earnings and Revenue Soundly Beat Estimates

    9:06 a.m. May 3, 2022

    - Josh Nathan-Kazis

  8. AbbVie Shares Drop Amid Missed Sales Expectations for Key Drugs

    10:02 a.m. April 29, 2022

    - Josh Nathan-Kazis

  9. AbbVie shares slide 2.8% premarket

    7:48 a.m. April 29, 2022

    - Ciara Linnane

  10. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/abbv

Other News on ABBV

  1. Marketplace Roundtable - Part 6 - Biotech And Healthcare

    5:24 p.m. June 30, 2022

    - Seeking Alpha

  2. 2 of the Safest Stocks to Buy in a Recession

    5:41 a.m. June 30, 2022

    - Motley Fool

  3. The Best Stocks to Invest $5,000 in Right Now

    11:23 a.m. June 29, 2022

    - Motley Fool

  4. CEO Stock Sales Raise Questions About Insider Trading

    11:00 a.m. June 29, 2022

    - Tom McGinty

  5. Investors Need Not Be Alarmed by Drug Patent Expirations

    3:02 p.m. June 28, 2022

    - GuruFocus.com

  6. Genmab: A Royalty Powerhouse With A Strong Pipeline

    10:26 a.m. June 28, 2022

    - Seeking Alpha

  7. AbbVie names new CFO

    9:33 a.m. June 28, 2022

    - Seeking Alpha

  8. AbbVie (ABBV) Gains As Market Dips: What You Should Know

    5:45 p.m. June 27, 2022

    - Zacks.com

  9. Amgen's Big Bet on Copycat Drugs Is Paying Off

    1:42 p.m. June 27, 2022

    - GuruFocus.com

  10. AbbVie's (ABBV) Rinvoq Gets CHMP Nod for New Indication

    11:08 a.m. June 27, 2022

    - Zacks.com

  11. 5 Best Dividend Stocks to Buy Now

    10:15 a.m. June 27, 2022

    - Motley Fool

  12. Is AbbVie About To Get A New Blockbuster Drug?

    6:13 a.m. June 27, 2022

    - Motley Fool

  13. 3 Top Dividend Stocks for Generating Passive Income

    5:57 a.m. June 26, 2022

    - Motley Fool

  14. The 3-Bucket SWAN Portfolio For The Good Times And Bad

    9:00 a.m. June 25, 2022

    - Seeking Alpha

  15. Loading more headlines...
/news/pressrelease/company/us/abbv

Press Releases on ABBV

  1. Loading more headlines...

Rates »

Link to MarketWatch's Slice.